SCHEMBL27693293

SCHEMBL27693293

CCC(C)(NC(=O)c1cc(Br)c2ccccc2c1O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
ERAP1 Q9NZ08 2/20 0.39
CXCR2 P25025 1/20 0.39
MCL1 Q07820 5/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CYP2C9 P11712 2/20 0.37
HSD17B10 Q99714 2/20 0.37
RCE1 Q9Y256 1/20 0.37
BCL2L1 Q07817 2/20 0.37
HMGB1 P09429 1/20 0.37
CXCL12 P48061 1/20 0.37
HSPD1 P10809 1/20 0.36
HSPE1 P61604 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27713026 0.85 KDM4E (0.73) KDM4EERAP1CXCR2MCL1MEN1
SCHEMBL28766910 0.85 KDM4E (0.52) KDM4EERAP1CXCR2MCL1MEN1
SCHEMBL27693288 0.81 CXCR2 (0.54) KDM4ECXCR2MEN1KMT2ANPSR1
SCHEMBL27713024 0.79 CXCR2 (0.52) KDM4EERAP1CXCR2MEN1KMT2A
SCHEMBL27693280 0.78 KDM4E (0.43) KDM4EERAP1CXCR2MEN1KMT2A
SCHEMBL9657406 0.77 BRD4 (0.47) KDM4ECXCR2MCL1MEN1KMT2A
SCHEMBL485029 0.77 KDM4E (0.54) KDM4EMCL1MEN1KMT2ANPSR1
SCHEMBL7586997 0.76 KDM4E (0.52) KDM4EMEN1KMT2ANPSR1ALDH1A1
SCHEMBL27693289 0.75 CXCR2 (0.57) ERAP1CXCR2MCL1BCL2L1THRB
SCHEMBL484865 0.73 KDM4E (0.44) KDM4EERAP1CXCR2MCL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN disclosed